Enzon Pharmaceuticals Announces 1-for-100 Reverse Stock Split Effective Today, Paving Way for Merger

summarizeSummary

Enzon Pharmaceuticals announced its 1-for-100 reverse stock split will become effective today, a mandatory step for its pending merger with Viskase.

check_boxKey Events

• Reverse Stock Split Effective

  Enzon Pharmaceuticals announced its 1-for-100 reverse stock split will become effective on March 24, 2026, at 4:30 p.m. Eastern Time.

• Trading on Split-Adjusted Basis

  Common Stock is expected to begin trading on a reverse stock split-adjusted basis on the OTCQB at market open on March 25, 2026.

• Merger Requirement Fulfilled

  The reverse stock split was a required step for the consummation of the previously disclosed transformational merger with Viskase, as noted in the company's recent 10-K filing.

auto_awesomeAnalysis

Enzon Pharmaceuticals announced the effective date for its previously disclosed 1-for-100 reverse stock split. This significant corporate action, which will see common stock trade on a split-adjusted basis starting March 25, 2026, is a critical step required for the consummation of the company's transformational merger with Viskase. While necessary for the merger, reverse stock splits are generally viewed negatively as they often indicate a company's struggle to maintain a viable share price.